All News #Library
Rare Diseases
GRIN Therapeutics Showcases Global Phase 3 Radiprodil Trial
03 Dec 2025 //
PR NEWSWIRE
Grin Therapeutics, Angelini Pharma collaborate on Radiprodil
27 May 2025 //
PR NEWSWIRE
GRIN Therapeutics Gets EU Orphan Designation for Radiprodil
06 May 2025 //
PR NEWSWIRE
GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil
01 Apr 2025 //
PR NEWSWIRE
GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil
17 Mar 2025 //
PR NEWSWIRE
GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil
25 Feb 2025 //
PR NEWSWIRE
GRIN Announces Initiation Of Astroscape Trial t of Tuberous Sclerosis
08 Oct 2024 //
PR NEWSWIRE

Market Place
Sourcing Support